Connect with us
European Gaming Congress 2024

Artificial Intelligence

SOPHiA GENETICS to Launch New Whole Genome Sequencing Capabilities

Published

on

sophia-genetics-to-launch-new-whole-genome-sequencing-capabilities

In collaboration with Microsoft and NVIDIA, SOPHiA GENETICS is developing a comprehensive whole genome analytical solution
BOSTON and ROLLE, Switzerland, May 29, 2024 /PRNewswire/ — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that it is collaborating with Microsoft and NVIDIA to leverage their expertise in technology and genomics to bring a streamlined and scalable whole genome sequencing (WGS) analytical solution to healthcare institutions, with the aim to make the solution available to customers before the end of the year.

The new WGS application from SOPHiA GENETICS will be designed to provide fully analyzed whole genome insights in an accelerated timeline, enabling researchers and clinicians to make data-driven decisions within the same day. This expedited speed will also increase opportunities for researchers and biotechnology companies to innovate rapidly across clinical research, drug discovery and care delivery with improved efficiency and effectiveness.
“By leveraging the powerful  technologies and capabilities offered by Microsoft Azure and NVIDIA, we are working to provide accurate, scalable, and rapid insights across multiple modalities, helping benefit our customers and, ultimately, patients, particularly those living with rare inherited disorders,” said Abhimanyu Verma, Chief Technology Officer, SOPHiA GENETICS. “We are confident our new WGS application will help provide an answer to existing customer needs and expedite research, diagnosis and treatment planning worldwide.”
The SOPHiA DDM™ Platform is a tech-agnostic, universal cloud-based Software-as-a-Service platform that enables healthcare institutions to get quick, robust, and actionable insights from their data. SOPHiA GENETICS’ technology analyzes genomic data, alongside other modalities – including diagnostic details, imaging, pathology, and medical assessments – to provide clear insights for institutions worldwide. The collective intelligence garnered from SOPHiA DDM™ supports discoveries, treatment decisions, and drug development efforts, benefiting patients with cancer and rare inherited genetic disorders.
As part of this collaboration, SOPHiA DDM™, hosted on Azure, will be powered by NVIDIA Parabricks for SOPHiA DDM™’s WGS application. NVIDIA Parabricks is a scalable genomics analysis software suite that leverages full-stack NVIDIA accelerated computing to process whole genomes in minutes. Compatible with all leading sequencing instruments, Parabricks supports diverse bioinformatics workflows and integrates artificial intelligence (AI) for accuracy and customization. SOPHiA GENETICS will also use powerful NVIDIA GPUs on Azure to process computationally heavy workloads, providing a scalable and efficient solution.
“Whole-genome sequencing has the potential to enhance and accelerate treatment plans and drug development efforts,” said George Vacek, Global Head of Genomics Alliances, NVIDIA. “Powered by NVIDIA Parabricks, SOPHiA DDM can process whole genomes in minutes, unlocking new possibilities and and helping drive meaningful impact for patients worldwide.”
“Microsoft aims to propel healthcare and life sciences into an exciting new era of personalized medicine, helping unlock transformative possibilities for patients worldwide,” said Peter Durlach, corporate vice president, Health & Life Sciences, Microsoft. “Our longstanding work with SOPHiA GENETICS and this latest collaboration leveraging Microsoft Azure and NVIDIA technology to create a new whole genome sequencing application, will have the potential to accelerate vital health research worldwide.”
For more information on SOPHiA GENETICS, visit SOPHiAGENETICS.COM, connect on LinkedIn, or visit the SOPHiA GENETICS booth at ESHG 2024.
About SOPHiA GENETICS  SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of the SOPHiA DDM™ Platform, which analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions. For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn. 
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. The information in this press release is about products that may or may not be available in different countries and, if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact [email protected] to obtain the appropriate product information for your country of residence. 
SOPHiA GENETICS Forward-Looking Statements:  This press release contains statements that constitute forward-looking statements. All statements other than statements of historical facts contained in this press release, including statements regarding our future results of operations and financial position, business strategy, products, and technology, as well as plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. Such statements are subject to risks and uncertainties, and actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including those described in our filings with the U.S. Securities and Exchange Commission. No assurance can be given that such future results will be achieved. Such forward-looking statements contained in this press release speak only as of the date hereof. We expressly disclaim any obligation or undertaking to update these forward-looking statements contained in this press release to reflect any change in our expectations or any change in events, conditions, or circumstances on which such statements are based, unless required to do so by applicable law. No representations or warranties (expressed or implied) are made about the accuracy of any such forward-looking statements. 
Logo – https://mma.prnewswire.com/media/1673202/SOPHiA_GENETICS_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/sophia-genetics-to-launch-new-whole-genome-sequencing-capabilities-302157975.html

Continue Reading
Advertisement

Artificial Intelligence

Eye Level holds its 2024 Eye Level Math Olympiad for students to test out their math skills.

Published

on

eye-level-holds-its-2024-eye-level-math-olympiad-for-students-to-test-out-their-math-skills.

SEOUL, South Korea, Oct. 17, 2024 /PRNewswire/ — Eye Level is hosting the 2024 Math Olympiad (ELMO 2024), inviting students from grades 1 to 8 worldwide to showcase their math skills. The competition will run from November 9 to December 1, following each country’s schedule across 15 countries.object

This Olympiad, part of the annual Eye Level Math Olympiad series established in 2004, offers students a valuable opportunity to assess and enhance their mathematical abilities. The test lasts approximately one hour and is designed to challenge students across various areas of math skills, covering most arithmetic and critical thinking domains. Questions are tailored to each grade level, allowing students to evaluate their skills objectively.All participants will receive a certificate of participation and a comprehensive analysis of their test results. Official results and winners will be announced in January 2025 on myeyelevel.com, with award ceremonies planned to be held locally for outstanding participants.
Registration is currently open on myeyelevel.com.
About Eye Level
Eye Level is an international provider of supplemental education services in Math and English with more than 2 million students having experienced its programs. Eye Level guides the students to learn at their own pace, and achieve their goals. With a growth-minded learning process, Eye Level helps students build good learning habits that become the foundation of great talent – setting them up for success in school and beyond. 
Photo – https://mma.prnewswire.com/media/2533165/p14_1_ELMO.jpg

View original content:https://www.prnewswire.co.uk/news-releases/eye-level-holds-its-2024-eye-level-math-olympiad-for-students-to-test-out-their-math-skills-302278994.html

Continue Reading

Artificial Intelligence

n2 Group Advances HPC/AI Portfolio by Acquiring Managed Services Company X-ISS

Published

on

n2-group-advances-hpc/ai-portfolio-by-acquiring-managed-services-company-x-iss

OXFORD, England, Oct. 17, 2024 /PRNewswire/ — n2 Group, the transformative computing technology investment company, announces the acquisition of high-performance computing (HPC) and AI specialists, X-ISS. The addition of X-ISS expands the Group’s portfolio– joining NAG, VSNi, BioTeam and STAC—as it accelerates advancements in technology and computation, underpinned by innovation, technical excellence, and a focus on long-term growth.

n2 Group invests selectively in technical computing companies with deep business impact in a variety of sectors, providing operational support and a collaborative approach to innovation and business transformation. The addition of X-ISS will further strengthen the Group’s already strong HPC/AI credentials, with NAG, STAC and BioTeam already adding to this space. 
X-ISS is a pioneer in Managed Services specifically designed for HPC/AI. With their in-depth understanding of hardware and software complexities within HPC and AI, they deliver highly impactful end-to-end services to clients through the integration, optimization and management of HPC/AI systems. The integration of X-ISS into n2 Group aligns with the Group vision of improving the accessibility, quality and robustness of computing solutions to enable greater productivity in industry. 
X-ISS will operate as an autonomous business within the n2 Group, maintaining its brand, identity and ethos. n2 Group’s status as an independent, member-backed organisation with no external financial stakeholders allows X-ISS to continue providing impartial advice based on the technology needs and challenges of its clients. Inter-group synergies will enable greater innovation and collaboration, advancing the Group’s position and long-term HPC/AI market impact. 
“X-ISS strengthens the n2 community in the strategically important area of HPC/AI”, said Adrian Scales, Snr Director of Investments and Partnerships at n2 Group. “As a respected boutique HPC service provider, X-ISS is helping clients navigate an increasingly complex landscape in terms of technologies and software integrations with AI and analytics. The acquisition strongly complements the Group’s existing HPC professional services capability, and we are delighted to have them on board.”
“This is an important milestone for X-ISS.”, said Deepak Khosla, CEO X-ISS, “The partnership with n2 Group will enable us to enhance our flagship ManagedHPC solution by leveraging n2’s complementary services and product developments, allowing us to deliver even greater value to our customers. As businesses face increasing challenges with complex technologies like AI and cloud computing, we’re now better equipped to support them with the same quality, passion, and partnership that defines X-ISS. I am excited about the opportunities this can bring for current and future X-ISS customers.”
About n2 Group  
At n2 Group we are transforming computing and technology investment with a radical new approach. Our businesses are all established, purpose-driven market-leaders in computing products or services. We stimulate long-term sustainable growth through group-level support in strategy, business development, innovation, and operations. With no shareholders or external financial interests, we reinvest all profits back into the group or to the community, reinforcing our commitment to positive social impact through technological advancements.    
n2 Group companies are at the forefront of computing and IT infrastructure, helping clients in various sectors to be more productive, innovative or reduce risk through advanced software and services. Rapidly expanding in high-performance computing, artificial intelligence, and scientific computing, our businesses maintain their unique brands and identities, but benefit from the expanded network available through the group.   
n2 Group Companies  
•  BioTeam: Scientific computing consultancy integrating technologies, data, and cultures to accelerate science. 
•  NAG: Advanced products and services in algorithms, optimization, high-performance computing and AI. 
•  STAC: Independent financial services technology research and community events. 
•  VSNi: Proven statistical solutions and data expertise driving innovation and success.  
•  X-ISS: Industry leading management and analytics solutions for HPC/AI systems.
For more detailed information and the latest updates, visit n2 Group. 
Logo – https://mma.prnewswire.com/media/2271328/n2_Group_Logo.jpgLogo –  https://mma.prnewswire.com/media/2533549/XISS_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/n2-group-advances-hpcai-portfolio-by-acquiring-managed-services-company-x-iss-302279433.html

Continue Reading

Artificial Intelligence

TIE 2024 Unveils a New Era of Innovation

Published

on

tie-2024-unveils-a-new-era-of-innovation

A New Era of AI-powered Innovation and Industrial Revolution: Driving Integration of Smart Tech into Daily Life.
TAIPEI, Oct. 17, 2024 /PRNewswire/ — The 2024 Taiwan Innotech Expo (TIE) kicked off today at Taipei World Trade Center with a focus on “Smart Tech Island –The New Era of AI.” This year’s event showcases over a thousand advanced technologies and research achievements across six key areas: digital information, data security, precision health, defense, green and renewable energy, and civil and military resilience, heralding a new chapter in the technological evolution of industries.

Online and On-Site Exhibitions Offers Comprehensive Access to the Latest Innovations
TIE 2024 offers a seamless blend of virtual and physical experiences. Visitors can explore technologies, register for events, and plan their visit online before the expo opens. During the expo period, the event website provides essential tools such as e-meeting requests, product maps, and program registration. For those who were unable to attend in person, online attendees can view exhibits and access business negotiation records even after the expo is closed, fostering ongoing collaboration and opportunities. As a leading platform for technological innovation exchanges in Taiwan, TIE 2024 showcases the nation’s advancements in AI and smart technologies. This event is anticipated to drive industry transformation and opens new chapters in technological innovation.
Official Website: https://tie.twtm.com.tw/en

View original content:https://www.prnewswire.co.uk/news-releases/tie-2024-unveils-a-new-era-of-innovation-302279310.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending